Jason Thonhoff

Company: Coya Therapeutics

Job title: Director, Clinical Development

Seminars:

Modulating the TREGs Pathway in ALS: Unveiling Innate Immunity’s Role in Neurodegeneration 1:30 pm

• To explore the role of regulatory T cell (Treg) dysfunction in neuroinflammation and as a contributing factor in the pathogenesis of ALS • To discuss ex vivo and in vivo therapeutic approaches that target Treg dysfunction to suppress neuroinflammation and potentially slow disease progression in ALS and other neurodegenerative diseases • To unveil plans…Read more

day: Conference Day Two Track B PM